Invivyd Inc (IVVD)
2.47
+0.04
(+1.65%)
USD |
NASDAQ |
May 15, 16:00
2.47
0.00 (0.00%)
After-Hours: 16:22
Invivyd Total Assets (Quarterly): 215.47M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 215.47M |
| December 31, 2023 | 229.18M |
| September 30, 2023 | 274.92M |
| June 30, 2023 | 315.41M |
| March 31, 2023 | 350.56M |
| December 31, 2022 | 383.17M |
| September 30, 2022 | 424.75M |
| Date | Value |
|---|---|
| June 30, 2022 | 484.61M |
| March 31, 2022 | 556.27M |
| December 31, 2021 | 620.09M |
| September 30, 2021 | 686.27M |
| June 30, 2021 | 397.99M |
| March 31, 2021 | 94.87M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
94.87M
Minimum
Mar 2021
686.27M
Maximum
Sep 2021
387.20M
Average
383.17M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | 652.68M |
| Viking Therapeutics Inc | 967.52M |
| Stoke Therapeutics Inc | 205.18M |
| 180 Life Sciences Corp | 5.260M |
| MAIA Biotechnology Inc | 7.567M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 36.97M |
| Shareholders Equity (Quarterly) | 178.50M |